Go Back Research Article November, 2004

Predictors of Herpes Simplex Virus Type 2 Antibody Positivity Among Persons With No History of Genital Herpes

Abstract

Background: The demographic, historical, and behavioral factors that predict a positive herpes simplex virus type 2 (HSV-2) antibody test in persons without a history of genital herpes have not been well-defined. Methods: Individuals (age 14–30 years) without a history of genital herpes completed a questionnaire and were offered free HSV-2 antibody testing. Factors from the questionnaire were correlated with the HSV-2 antibody result. Results: Univariate analysis showed that female gender was significantly associated with positive test results. In gender-specific, multiple logistic regression models, a positive HSV-2 antibody test among men was associated with older age, non-white race, and a history of sexually transmitted disease (STD). Gender-specific symptom scores from the questionnaire were not predictive in either gender, but the gender-common symptom score was marginally predictive of a positive HSV-2 antibody test in women. Among women, older age, non-white race, and STD history predicted a positive test. Conclusions: Among young persons with no history of genital herpes who agreed to HSV-2 antibody testing, increasing age, non-white race, and a history of an STD were predictors of a positive test. A history of frequent pain, itching, burning, and rashes in the anogenital region was marginally associated with positive HSV-2 tests in women. These results might help guide selective use of HSV-2 antibody screening.

Keywords

hsv herpes simplex virus type 2 (hsv-2) antibody positivity genital herpes sexually transmitted disease (std) hsv-2 screening sexual health std risk factors hsv-2 testing hsv-2 predictors non-white race gender differences young adults sexual behavior std history hsv-2 prevalence age-related risk hsv-2 symptoms public health hsv-2 epidemiology viral infections sexual risk assessment hsv-2 diagnosis asymptomatic hsv-2 anogenital symptoms
Document Preview
Download PDF
Details
Volume 31
Issue 11
Pages 676–681
ISSN 1537-4521
Impact Metrics